Royalty Pharma RPRX Short-Term Investments
Short-Term Investments at other companies
Other financials
Where this comes from
Reported directly by Royalty Pharma in its filing.
Tagged under the XBRL concept us-gaap:AvailableForSaleSecuritiesDebtSecuritiesCurrent.
The official record: Royalty Pharma’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Royalty Pharma's short-term investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Royalty Pharma's short-term investments?
- Royalty Pharma (RPRX) reported short-term investments of $21.9M in Q1 2026.
- How has Royalty Pharma's short-term investments changed year-over-year?
- Royalty Pharma's short-term investments increased by 81.0% year-over-year, from $12.1M to $21.9M.
- What is the long-term trend for Royalty Pharma's short-term investments?
- Over 5 years (2020 to 2025), Royalty Pharma's short-term investments has grown at a -23.1% compound annual growth rate (CAGR), from $69.98M to $18.8M.
- What does short-term investments mean?
- Marketable securities and other investments with maturities between three months and one year, providing yield above cash while maintaining liquidity.